Don’t fall for the ‘next best action’ trap – AI in pharma sales
Pf is proud to announce a new, free webinar with OKRA focused on AI in pharma sales. Called ‘Why Next Best Action is not...
Building the trust – post COVID-19
Simon Grime, Executive Director at Wilmington Healthcare discusses what needs to be done to build trust between pharma and health in a post COVID-19...
The new NHS stakeholder map
Paul Midgley, of Wilmington Healthcare, looks at the new NHS stakeholder map and explores the latest changes in NHS structure, which were outlined in...
Remote engagement with HCPs after COVID-19
Mick O’Leary, Regional President of Ashfield Commercial and Patient Solutions, looks at how the pharmaceutical industry can create a vision for the ‘new normal’...
APM study reveals the contribution of project management in pharma and life science
A study by the Association for Project Management has revealed the contribution of projects and project management in pharma and life sciences. Rebecca Fox, Head...
Pf Webinars: Shaping healthcare markets to serve real brand purpose
Pf's third FREE webinar in conjunction with Triducive and E4H focuses on shaping healthcare markets to serve real brand purpose. As healthcare markets are evolve...
COVID-19 forces radical changes in NHS finance
Oli Hudson, Content Director at Wilmington Healthcare, discusses how COVID-19 is forcing radical changes in NHS finance and gives an overview of the latest...
Winning pharma brands: Changing the rules of a market
Understanding the bigger questions that winning pharma brands ask to change the market and redefine the playing field. The global health emergency that we are...
Pf Webinars: Pharma and Integrated Care Systems – How to make your brand relevant
Pf is proud to announce a new FREE webinar series with Triducive. The first webinar, focuses on pharma and integrated care systems. In this...
Evolving pharma key account management in a changing NHS
Oli Hudson, Content Director at Wilmington Healthcare, gives an overview of a recent webinar on how pharma key account management must evolve in a...
Latest articles
NICE recommends Tagrisso for patients with early-stage lung cancer
Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as an adjuvant...
JCVI responds to Omicron variant and updates its guidance
The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A...
EC grants marketing authorisation for breast cancer treatment Trodelvy
The European Commission (EC) has granted marketing authorization for Gilead Sciences’ Trodelvy® (sacituzumab govitecan), as a monotherapy indicated for the treatment of adult patients with...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
NICE recommends Tagrisso for patients with early-stage lung cancer
Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as an adjuvant...
A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT
What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...
JCVI responds to Omicron variant and updates its guidance
The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A...
Understanding the role of the MSL
Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...